Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1200/OP.20.00286

http://scihub22266oqcxt.onion/10.1200/OP.20.00286
suck pdf from google scholar
32453656!ä!32453656

suck abstract from ncbi


Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32453656      JCO+Oncol+Pract 2020 ; 16 (9): 579-586
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Management of Lung Cancer During the COVID-19 Pandemic #MMPMID32453656
  • Singh AP; Berman AT; Marmarelis ME; Haas AR; Feigenberg SJ; Braun J; Ciunci CA; Bauml JM; Cohen RB; Kucharczuk JC; Shulman LN; Langer CJ; Aggarwal C
  • JCO Oncol Pract 2020[Sep]; 16 (9): 579-586 PMID32453656show ga
  • Coronavirus disease 2019 (COVID-19) has had a devastating impact around the world. With high rates of transmission and no curative therapies or vaccine yet available, the current cornerstone of management focuses on prevention by social distancing. This includes decreased health care contact for patients. Patients with lung cancer are a particularly vulnerable population, where the risk of mortality from cancer must now be balanced by the potential risk of a life-threatening infection. In these unprecedented times, a collaborative and multidisciplinary approach is required to streamline but not compromise care. We have developed guidelines at our academic cancer center to standardize management of patients with lung cancer across our health care system and provide guidance to the larger oncology community. We recommend that general principles of lung cancer treatment continue to be followed in most cases where delays could result in rapid cancer progression. We recognize that our recommendations may change over time based on clinical resources and the evolving nature of the COVID-19 pandemic. In principle, however, treatment paradigms must continue to be individualized, with careful consideration of risks and benefits of continuing or altering lung cancer-directed therapy.
  • |*Pandemics[MESH]
  • |Betacoronavirus/pathogenicity[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/complications/epidemiology/*therapy/virology[MESH]
  • |Delivery of Health Care/trends[MESH]
  • |Disease Management[MESH]
  • |Humans[MESH]
  • |Infection Control/methods[MESH]
  • |Lung Neoplasms/complications/epidemiology/*therapy/virology[MESH]
  • |Medical Oncology/methods[MESH]
  • |Pneumonia, Viral/complications/epidemiology/*therapy/virology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box